Routine

Insulin initiation & titration (type 2 diabetes)

insulin · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Structured starting and dose adjustment of insulin in type 2 diabetes when oral and injectable non-insulin agents no longer achieve targets. Usually begins with basal insulin, advancing to intensified regimens as needed.

Red flags

  • Recurrent or severe hypoglycaemia
  • Rapid unexplained weight loss or ketosis (consider type 1/LADA)
  • Hypoglycaemia unawareness in a driver
  • Very high insulin requirements without effect (adherence/intercurrent illness)

Assessment

Differential diagnosis

  • Suboptimal adherence to existing therapy
  • Steroid-induced hyperglycaemia
  • Latent autoimmune diabetes of adults (LADA)
  • Pancreatic diabetes
  • Undiagnosed infection/stress hyperglycaemia

Investigations

  • HbA1c and self-monitored glucose profiles
  • Renal function and weight/BMI
  • Consider C-peptide and GAD antibodies if LADA suspected
  • Review of current regimen and adherence
  • Assessment of hypoglycaemia awareness and driving status

Management

  • Confirm failure of optimised non-insulin therapy and agree individualised HbA1c target
  • Continue metformin and (where possible) GLP-1 agonist/SGLT2 inhibitor
  • Stop or reduce sulfonylureas as insulin starts to limit hypoglycaemia
  • Start basal insulin ~10 units or 0.1-0.2 units/kg at a consistent time
  • Teach injection technique, glucose monitoring and hypoglycaemia management
  • Titrate basal dose by 2-4 units every few days to fasting target ~5-7 mmol/L
  • If fasting at target but HbA1c high, add prandial insulin or switch to premixed/basal-bolus
  • Assess driving (DVLA rules), weight gain and hypoglycaemia at each review
  • Reassess whether insulin remains necessary if lifestyle/weight improve

Drugs & doses

Insulin glargine U100/U300 or degludec 10 units SC nocte, titrated
Insulin isophane (NPH) once-twice daily as cheaper basal option
Insulin aspart/lispro with meals for prandial cover
Premixed insulin (e.g. 30/70) twice daily as an alternative regimen

Disposition

Initiate and titrate in primary care/diabetes clinic with structured education; refer to specialist team for suspected type 1/LADA or persistent instability.

Complications & pitfalls

  • Hypoglycaemia
  • Weight gain
  • Injection-site lipohypertrophy
  • Over-basalisation (rising dose without benefit)
  • Loss of driving licence if poorly controlled

Exam pearls

  • Keep metformin and SGLT2/GLP-1 agents going to limit insulin dose and weight gain
  • Over-basalisation (basal >0.5 units/kg with high post-meal glucose) needs prandial cover, not more basal
  • Degludec and glargine U300 have flatter profiles and less nocturnal hypoglycaemia
  • Review driving and occupational implications before starting insulin

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.